EDUARDO SETTI,GANG LIU,MARK W. HOLLADAY,MICHAEL J. HADD,QI CHAO,SUNNY ABRAHAM
申请号:
BRPI1013347
公开号:
BRPI1013347A2
申请日:
2010.02.26
申请国别(地区):
BR
年份:
2016
代理人:
摘要:
Provided herein are quinazoline compounds of formula (I): The compounds are useful for treatment of JAK kinase mediated diseases, including JAK2 kinase-, JAK3 kinase- or TYK2 kinase-mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.